Position in BLLN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$9,599,419
+$7,013,358 QoQ
Shares Held
121,604
+284.8% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026UBS Group AG holds $3,686,646,466 across 46 Diagnostics & Research names. BLLN ranks #20 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,453,453 | $1,205,945,748 | |
| 2 | DHR |
Danaher Corp /De/
|
2,549,143 | $483,317,510 | |
| 3 | WAT |
Waters Corp /De/
|
640,339 | $190,692,952 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
305,167 | $171,470,284 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
340,433 | $163,472,521 | |
| 6 | LH |
Labcorp Holdings Inc.
|
564,529 | $150,621,981 | |
| 7 | ILMN |
Illumina, Inc.
|
1,162,435 | $143,281,736 | |
| 8 | DGX |
Quest Diagnostics Inc
|
702,337 | $137,644,004 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,599,419 | 121,604 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,586,061 | 31,599 | Shares | Defined | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||